Acute hepatitis C in patients with HIV

Seminars in Liver Disease

Volumn 32, Issue 2, 2012, Pages 130-137

  Boesecke, Christoph ^a   Rockstroh, Jürgen Kurt ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

acute hepatitis C virus; HIV; human immunodeficiency virus; interferon; ribavirin; treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

ACUTE HEPATITIS; ACUTE HEPATITIS C; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ASYMPTOMATIC INFECTION; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG RESPONSE; GENETIC ASSOCIATION; GENOTYPE; GERMANY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FIBROSIS; NETHERLANDS; PRIORITY JOURNAL; RECURRENCE RISK; REINFECTION; REVIEW; RISK ASSESSMENT; SEROCONVERSION; SINGLE NUCLEOTIDE POLYMORPHISM; SUSTAINED VIROLOGIC RESPONSE; TREATMENT DURATION; TREATMENT OUTCOME; VIRAL CLEARANCE; VIRUS REPLICATION;

ANTIVIRAL AGENTS; AUSTRALIA; COINFECTION; EUROPE; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERFERONS; MALE; RIBAVIRIN; UNITED STATES;

EID: 84863213479     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0032-1316468     Document Type: Review

References (86)

1. Luetkemeyer A, Hare CB, Stansell J., et al. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr: 2006; 41 1 31 36
2. Cox AL, Page K, Bruneau J., et al. Rare birds in North America: acute hepatitis C cohorts. Gastroenterology: 2009; 136 1 26 31
3. Giraudon I, Ruf M, Maguire H., et al. Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002-2006: is this an outbreak? Sex Transm Infect: 2008; 84 2 111 115
4. Ruf M, Cohuet S, Maguire H., et al. SNAHC Steering Group Setting up an enhanced surveillance of newly acquired hepatitis C infection in men who have sex with men: a pilot in London and South East region of England. Euro Surveill: 2008; 13 47
5. Vogel M, Deterding K, Wiegand J., et al. German Hepatitis Group; Hep-Net. Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infection. Clin Infect Dis: 2009; 49 2 317 319, author reply 319
6. Gambotti L, Batisse D, Colin-de-Verdiere N., et al. Acute hepatitis C collaborating group Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004. Euro Surveill: 2005; 10 5 115 117
7. Morin T, Pariente A, Lahmek P.; Investigator Group of ANGH, SPILF, FNPRH. Favorable outcome of acute occupational hepatitis C in healthcare workers: a multicenter French study on 23 cases. Eur J Gastroenterol Hepatol: 2011; 23 6 515 520
8. Urbanus AT, van de Laar TJ, Stolte IG., et al. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS: 2009; 23 12 F1 F7
9. Rauch A, Rickenbach M, Weber R., et al. Swiss HIV Cohort Study. Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. Clin Infect Dis: 2005; 41 3 395 402
10. Gallotta G, Gali L, De Bona A., et al. Acute hepatitis C virus in HIV co-infected men who have sex with men: Milan, 1996-2007. Paper presented at: 4th International HIV and Hepatitis Co-infection; June 19-21, 2008; Madrid, Spain.
11. Matthews GV, Hellard M, Haber P., et al. Australian Trial in Acute Hepatitis C Study Group Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C. Clin Infect Dis: 2009; 48 5 650 658
12. Sherman KE, Rouster SD, Horn PS. Comparison of methodologies for quantification of hepatitis C virus (HCV) RNA in patients coinfected with HCV and human immunodeficiency virus. Clin Infect Dis: 2002; 35 4 482 487
13. Backus LI, Phillips BR, Boothroyd DB., et al. Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr: 2005; 39 5 613 619
14. United Nations. Report UNAIDS. 2008. Available at: http://data.unaids. org/pub/GlobalReport/2008/jc1511-gr08-executivesummary-en.pdf. Accessed October 18, 2011
15. Soriano V, Mocroft A, Rockstroh J., et al. EuroSIDA Study Group Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe. J Infect Dis: 2008; 198 9 1337 1344
16. Matthews GV, Pham ST, Hellard M., et al. ATAHC Study Group Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C. Clin Infect Dis: 2011; 52 6 803 811
17. Arends JE, Lambers FA, van der Meer JT., et al. The Netherlands Society for AIDS Physicians-NVAB. Treatment of acute hepatitis C virus infection in HIV+ patients: Dutch recommendations for management. Neth J Med: 2011; 69 1 43 49
18. Neukam K, Nattermann J, Rallón N., et al. Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype. HIV Med: 2011; 12 8 487 493
19. Pfafferott K, Gaudieri S, Ulsenheimer A., et al. Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity. PLoS ONE: 2011; 6 2 e16797
20. Bottieau E, Apers L, Van Esbroeck M, Vandenbruaene M, Florence E. Hepatitis C virus infection in HIV-infected men who have sex with men: sustained rising incidence in Antwerp, Belgium, 2001-2009. Euro Surveill: 2010; 15 39 19673
21. Barfod TS, Omland LH, Katzenstein TL. Incidence and characteristics of sexually transmitted acute hepatitis C virus infection among HIV-positive men who have sex with men in Copenhagen, Denmark during four years (2006-2009): a retrospective cohort study. Scand J Infect Dis: 2011; 43 2 145 148
22. Dionne-Odom J, Osborn MK, Radziewicz H, Grakoui A, Workowski K. Acute hepatitis C and HIV coinfection. Lancet Infect Dis: 2009; 9 12 775 783
23. Hull M, Boesecke C. Personal conversation. June 2, 2011
24. Remis R. A Study to Characterize the Epidemiology of Hepatitis C Infection in Canada, 2002. Final Report. Public Health Agency of Canada. Available at: http://www.phac-aspc.gc.ca/hepc/pubs/hepc2002/index-eng.php. Accessed October 19, 2011
25. Lebanese Republic, Ministry of Public Health UNGASS Country Progress Report Lebanon March 2010. Available at: http://www.unaids.org/en/dataanalysis/ monitoringcountryprogress/2010progressreportssubmittedbycountries/ lebanon-2010-country-progress-report-en.pdf. Accessed October 19, 2011
26. Soriano V, Boesecke C, Rockstroh JK. Personal conversation. June 2, 2011
27. Boesecke C, Stellbrink HJ, Mauss S., et al. Does baseline HCV genotype have an impact upon treatment outcome of acute HCV infection in HIV co-infected individuals? Abstract presented at: 18th Conference on Retroviruses and Opportunistic Infections; February 27-March 2, 2011; Boston, MA
28. Sun HY, Chang SY, Yang TY., et al. Recent Hepatitis C Virus Infection in HIV-Positive Patients in Taiwan: Incidence and Risk Factors. J Clin Microbiol: 2012; 50 3 781 787
29. Lee HC, Ko NY, Lee NY, Chang CM, Ko WC. Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000-2005: upsurge in hepatitis C virus infections among injection drug users. J Formos Med Assoc: 2008; 107 5 404 411
30. Larsen C, Alric L, Auperin I., et al. Acute hepatitis C in HIV-infected men who have sex with men in France in 2006 and 2007. Paper presented at: 58th Annual Meeting of the American Association for the Study of the Liver; November 2-6, 2007; Boston, MA
31. Clausen LN, Weis N, Astvad K., et al. Interleukin-28B polymorphisms are associated with hepatitis C virus clearance and viral load in a HIV-1-infected cohort. J Viral Hepat: 2011; 18 4 e66 e74
32. van der Helm JJ, Prins M, del Amo J., et al. CASCADE Collaboration. The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS: 2011; 25 8 1083 1091
33. Fierer D, Fishman S, Uriel A., et al. Characterization of an outbreak of acute HCV infection in HIV-infected men in New York City. Paper presented at: 16th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2009; Montreal, Canada
34. Hung CC, Chen MY, Hsieh SM, Hsiao CF, Sheng WH, Chang SC. Impact of chronic hepatitis C infection on outcomes of patients with an advanced stage of HIV-1 infection in an area of low prevalence of co-infection. Int J STD AIDS: 2005; 16 1 42 48
35. Schmidt AJ, Rockstroh JK, Vogel M., et al. Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germanya case-control study. PLoS ONE: 2011; 6 3 e17781
36. van de Laar TJ, Paxton WA, Zorgdrager F., et al. Sexual transmission of hepatitis C virus in human immunodeficiency virus-negative men who have sex with men: a series of case reports. Sex Transm Dis: 2011; 38 2 102 104
37. Nguyen O, Sheppeard V, Douglas MW, Tu E, Rawlinson W. Acute hepatitis C infection with evidence of heterosexual transmission. J Clin Virol: 2010; 49 1 65 68
38. Marincovich B, Castilla J, del Romero J., et al. Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples. Sex Transm Infect: 2003; 79 2 160 162
39. Vandelli C, Renzo F, Romanò L., et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol: 2004; 99 5 855 859
40. Daniels D, Grytdal S, Wasley A.; Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ: 2009; 58 3 1 27
41. Carey JW, Mejia R, Bingham T., et al. Drug use, high-risk sex behaviors, and increased risk for recent HIV infection among men who have sex with men in Chicago and Los Angeles. AIDS Behav: 2009; 13 6 1084 1096
42. Thiede H, Jenkins RA, Carey JW., et al. Determinants of recent HIV infection among Seattle-area men who have sex with men. Am J Public Health: 2009; 99 Suppl 1 S157 S164
43. Götz HM, van Doornum G, Niesters HG, den Hollander JG, Thio HB, de Zwart O. A cluster of acute hepatitis C virus infection among men who have sex with menresults from contact tracing and public health implications. AIDS: 2005; 19 9 969 974
44. van de Laar T, Pybus O, Bruisten S., et al. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology: 2009; 136 5 1609 1617
45. Vogel M, van de Laar T, Kupfer B., et al. Phylogenetic analysis of acute hepatitis C virus genotype 4 infections among human immunodeficiency virus-positive men who have sex with men in Germany. Liver Int: 2010; 30 8 1169 1172
46. Thomson EC, Nastouli E, Main J., et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS: 2009; 23 1 89 93
47. Scott C, Day S, Low E, Sullivan A, Atkins M, Asboe D. Unselected hepatitis C screening of men who have sex with men attending sexual health clinics. J Infect: 2010; 60 5 351 353
48. Cicconi P, Cozzi-Lepri A, Phillips A., et al. ICoNA Study Group Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy? AIDS: 2007; 21 5 599 606
49. Stellbrink HJ, Schewe CK, Vogel M., et al. Increasing numbers of acute hepatitis C infections in HIV-infected MSM and high reinfection rates following SVR. J Int AIDS Soc: 2010; 13 Suppl 4 200
50. Lambers F, Prins M, Thomas X., et al. High incidence rate of HCV reinfection after treatment of acute HCV infection in HIV-infected MSM in Amsterdam. Poster presented at: 18th Conference on Retroviruses and Opportunistic Infections; February 27-March 2, 2011; Boston, MA
51. Grebely J, Petoumenos K, Hellard M., et al. ATAHC Study Group Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection. Hepatology: 2010; 52 4 1216 1224
52. Jones L, Uriel A, Kaplan D., et al. Natural history and treatment outcome of acute hepatitis C with and without HIV co-infection in a North American cohort. Paper presented at: 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2008); October 31-November 4, 2008; San Francisco, CA
53. Thomson EC, Fleming VM, Main J., et al. Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut: 2011; 60 6 837 845
54. Thomas DL, Astemborski J, Rai RM., et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA: 2000; 284 4 450 456
55. Gilleece YC, Browne RE, Asboe D., et al. Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin. J Acquir Immune Defic Syndr: 2005; 40 1 41 46
56. Thomson EC, Fleming VM, Main J., et al. Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut: 2011; 60 6 837 845
57. Thomas DL, Thio CL, Martin MP., et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature: 2009; 461 7265 798 801
58. Rauch A, Kutalik Z, Descombes P., et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology: 2010; 138 4 1338 1345, 1345.e1-e7
59. Ge D, Fellay J, Thompson AJ., et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature: 2009; 461 7262 399 401
60. Fierer DS, Uriel AJ, Carriero DC., et al. Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. J Infect Dis: 2008; 198 5 683 686
61. Vogel M, Page E, Boesecke C., et al. Liver fibrosis progression after acute HCV infection (AHC) in HIV-positive individuals. Clin Infect Dis: 2012; 54 4 556 9
62. Vogel M, Boesecke C, Rockstroh JK. Acute hepatitis C infection in HIV-positive patients. Curr Opin Infect Dis: 2011; 24 1 1 6
63. Vogel M, Page E, Matthews G., et al. Use of week 4 HCV RNA after acute HCV infection to predict chronic HCV infection. Paper presented at: 17th Conference on Retroviruses and Opportunistic Infections; February 16-19, 2010; San Francisco, CA
64. Gerlach JT, Diepolder HM, Zachoval R., et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology: 2003; 125 1 80 88
65. Deterding K, Gruner NH, Wiegand J., et al. Early versus delayed treatment of acute hepatitis C: the German HEP-NET Acute HCV-III Studya randomized controlled trial. 44th Annual Meeting of the European Association for the Study of the Liver (EASL 2009); April 27-26, 2009; Copenhagen, Denmark
66. Dore GJ, Hellard M, Matthews GV., et al. Effective treatment of injecting drug users with recently acquired hepatitis C virus infection. Gastroenterology: 2010; 138 1 123 135.e2
67. Boesecke C, Rockstroh JK. Treatment of acute hepatitis C infection in HIV-infected patients. Curr Opin HIV AIDS: 2011; 6 4 278 284
68. The European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel. Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS Treatment Network (NEAT) consensus conference. AIDS: 2011; 25 4 399 409
69. Vogel M, Nattermann J, Baumgarten A., et al. Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals. Antivir Ther: 2006; 11 8 1097 1101
70. Schnuriger A, Dominguez S, Guiguet M., et al. Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus. AIDS: 2009; 23 16 2079 2089
71. Dominguez S, Ghosn J, Valantin MA., et al. Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients. AIDS: 2006; 20 8 1157 1161
72. Kruk A. Efficacy of acute HCV treatment with peg-interferon alfa-2b and ribavirin in HIV-infected patients. Paper presented at: 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment; July 24-27, 2005; Rio de Janeiro, Brazil
73. Serpaggi J, Chaix ML, Batisse D., et al. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy. AIDS: 2006; 20 2 233 240
74. Piroth L, Larsen C, Binquet C., et al. Steering Committee of the HEPAIG Study. Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study. Hepatology: 2010; 52 6 1915 1921
75. Núñez M, Miralles C, Berdún MA., et al. PRESCO Study Group Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial. AIDS Res Hum Retroviruses: 2007; 23 8 972 982
76. Vogel M, Ahlenstiel G, Hintsche B., et al. The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive Individuals. Eur J Med Res: 2010; 15 3 102 111
77. Arends J, Mudrikova T, Wensing A., et al. High percentage of non-response with peginterferon-alfa-2a monotherapy for the treatment of acute hepatitis C in HIV infected patients. Paper presented at: 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2009);September 12-15, 2009; San Francisco, CA
78. Matthews G, Grebely J, Hellard M., et al. Differences in early virological decline in individuals treated within the Australian trial in acute HCV suggest a potential benefit for the use of ribavirin. Paper presented at: 45th Annual Meeting of the European Association for the Study of the Liver (EASL); April 14-18, 2010; Vienna, Austria
79. Hare B, Marks K, Luetkemeyer A., et al. Kinetically guided PEG Alfa-2a and RBV therapy for HIV+ adults with acute HCV infection. Paper presented at: 17th Conference on Retroviruses and Opportunistic Infection; February 16-19, 2010; San Francisco, CA
80. Hare B, Marks K, Luetkemeyer A., et al. Kinetically guided PEG Alfa-2a and RBV therapy for HIV+ adults with acute HCV infection. Paper presented at: 18th Conference on Retroviruses and Opportunistic Infection; February 27-March 2, 2011; Boston, MA
81. Nattermann J, Vogel M, Nischalke HD., et al. Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis C. J Infect Dis: 2011; 203 5 595 601
82. Vogel M, Dominguez S, Bhagani S., et al. Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohort. Antivir Ther: 2010; 15 2 267 279
83. Lambers F, Brinkman K, Schinkel J., et al. Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration. AIDS: 2011; 19;25 10 1333 1336
84. Matthews GV, Dore GJ. Optimal duration of treatment for acute hepatitis C in human immunodeficiency virus-positive individuals? Hepatology: 2011; 53 3 1055 1056, author reply 1056-1057
85. Dorward J, Garrett N, Scott D., et al. Successful treatment of acute hepatitis C virus in HIV positive patients using the European AIDS Treatment Network guidelines for treatment duration. J Clin Virol: 2011; 52 4 367 369
86. Carlsson T, Quist A, Weiland O. Rapid viral response and treatment outcome in genotype 2 and 3 chronic hepatitis C: comparison between two HCV RNA quantitation methods. J Med Virol: 2008; 80 5 803 807